Nephrogenic syndrome of inappropriate antidiuresis

New England Journal of Medicine

Volumn 352, Issue 18, 2005, Pages 1884-1890

  Feldman, Brian J ^a   Rosenthal, Stephen M ^a   Vargas, Gabriel A ^b   Fenwick, Raymond G ^c   Huang, Eric A ^a   Matsuda Abedini, Mina ^b   Lustig, Robert H ^a   Mathias, Robert S ^b   Portale, Anthony A ^b   Miller, Walter L ^a   Gitelman, Stephen E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; CYSTEINE; LEUCINE; VASOPRESSIN V2 RECEPTOR; VASOPRESSIN RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CASE REPORT; CLINICAL FEATURE; CODON; CONTROLLED STUDY; DNA SEQUENCE; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INFANT; KIDNEY DISEASE; LABORATORY TEST; MALE; MISSENSE MUTATION; NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; AMINO ACID SEQUENCE; BLOOD; CHEMISTRY; DIURESIS; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; METABOLIC DISORDER; MOLECULAR GENETICS; PHYSIOLOGY; SCHWARTZ BARTTER SYNDROME; SEIZURE; URINE;

AMINO ACID SEQUENCE; ARGININE VASOPRESSIN; DIURESIS; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION; HUMANS; HYPONATREMIA; INAPPROPRIATE ADH SYNDROME; INFANT; MALE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; RECEPTORS, VASOPRESSIN; SEIZURES; TRANSFECTION; URINE; WATER-ELECTROLYTE IMBALANCE;

EID: 17944380530     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa042743     Document Type: Article

References (26)

1. Robertson GL. Antidiuretic hormone: normal and disordered function. Endocrinol Metab Clin North Am 2001;30:671-94.
2. Morello JP, Bichet DG. Nephrogenic diabetes insipidus. Annu Rev Physiol 2001;63: 607-30.
3. Bartter FC, Schwartz WB. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 1967;42:790-806.
4. Bichet DG, Arthus MF, Lonergan M, et al. X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis. J Clin Invest 1993;92: 1262-8.
5. Birnbaumer M, Gilbert S, Rosenthal W. An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs/ adenylyl cyclase system. Mol Endocrinol 1994;8:886-94.
6. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 2000;106:253-62.
7. Stables J, Scott S, Brown S, et al. Development of a dual glow-signal firefly and Renilla luciferase assay reagent for the analysis of G-protein coupled receptor signalling. J Recept Signal Transduct Res 1999;19:395-410.
8. Fluck CE, Martens JW, Conte FA, Miller WL. Clinical, genetic, and functional characterization of adrenocorticotropin receptor mutations using a novel receptor assay, J Clin Endocrinol Metab 2002;87:4318-23.
9. Rosenthal W, Antaramian A, Gilbert S, Birnbaumer M. Nephrogenic diabetes insipidus: a V2 vasopressin receptor unable to stimulate adenylyl cyclase. J Biol Chem 1993; 268:13030-3.
10. Pierce KL, Premont RT, Lefkowitz RJ. Seven-transmembrane receptors. Nat Rev Mol Cell Biol 2002;3:639-50.
11. Spiegel AM, Weinstein LS. Inherited diseases involving G proteins and G protein-coupled receptors. Annu Rev Med 2004;55: 27-39.
12. Seifert R, Wenzel-Seifert K. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch Pharmacol 2002;366:381-416.
13. Bockaert J, Pin JP. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J 1999;18:1723-9.
14. Luttrell LM, Lefkowitz RT. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci 2002;115:455-65.
15. Probst WC, Snyder LA, Schuster DI, Brosius J, Sealfon SC. Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol 1992;11:1-20.
16. Barak LS, Oakley RH, Laporte SA, Caron MG. Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus. Proc Natl Acad Sci U S A 2001; 98:93-8.
17. Parnot C, Miserey-Lenkei S, Bardin S, Corvol P, Clauser E. Lessons from constitutively active mutants of G protein-coupled receptors. Trends Endocrinol Metab 2002; 13:336-43.
18. Morin D, Cotte N, Balestre MN, et al. The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities. FEBS Lett 1998;441:470-5.
19. Hirsch AT, Dzau VJ, Majzoub JA, Creager MA. Vasopressin-mediated forearm vasodilation in normal humans: evidence for a vascular vasopressin V2 receptor. J Clin Invest 1989;84:418-26.
20. Kaufmann JE, Iezzi M, Vischer UM. Desmopression (DDAVP) induces NO production in human endothelial cells via V2 receptor-and cAMP-mediated signaling. J Thromb Haemost 2003;1:821-8.
21. Mannucci PM, Ruggeri ZM, Pared FI, Capitanio A. 1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrand's diseases. Lancet 1977;1:869-72.
22. Bichet DG, Razi M, Lonergan M, et al. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl J Med 1988;318:881-7.
23. Zerbe R, Stropes L, Robertson G. Vasopressin function in the syndrome of inappropriate antidiuresis. Annu Rev Med 1980; 31:315-27.
24. Verbalis JG. Vasopressin V2 receptor antagonists. J Mol Endocrinol 2002;29:1-9.
25. Huang EA, Geller DH, Gitelman SE. The use of oral urea in the treatment of chronic syndrome of inappropriate antidiuretic hormone secretion (SIADH) in children. Pediatr Res 2004;55:161A. abstract.
26. Decaux G, Prospert F, Penninckx R, Namias B, Soupart A. 5-Year treatment of the chronic syndrome of inappropriate secretion of ADH with oral urea. Nephron 1993; 63:468-70.